NCT04023435 (PNEdepress) is a NA clinical trial of PNE edcuation in Chronic Low-back Pain, sponsored by St. Ambrose University.

Who is sponsoring NCT04023435?

NCT04023435 is sponsored by St. Ambrose University.

What drugs are being tested in NCT04023435?

Interventions in NCT04023435: PNE edcuation.

What condition does NCT04023435 study?

NCT04023435 studies Chronic Low-back Pain, Depression.

Is NCT04023435 still recruiting?

NCT04023435 is currently completed. Last updated 17 January 2023.

Last reviewed 2023-01-17 · How we verify

NCT04023435: PNEdepress

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pain Neuroscience Education for Depression

Completed NA Last updated 17 January 2023

What this trial tests

NA trial testing PNE edcuation in Chronic Low-back Pain in 30 participants. Completed in 5 November 2019.

Timeline

1 June 2019

Primary endpoint
1 September 2019

5 November 2019

Quick facts

Lead sponsor	St. Ambrose University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 June 2019
Primary completion	1 September 2019
Estimated completion	5 November 2019
Sites	1 location across United States

Drugs / interventions tested

PNE edcuation

Conditions studied

Chronic Low-back Pain — all drugs for Chronic Low-back Pain →
Depression — all drugs for Depression →

Sponsor

St. Ambrose University

Who can join

Adults 18 to 90, any sex, with Chronic Low-back Pain or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will look at the effects of Pain Neuroscience Education on a Depression outcome tool in patients with chronic low back pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Low-back Pain

Currently open trials in the same condition.

NCT06891625 — Movement Performance in Persons With Chronic Back Pain · NA · recruiting
NCT06568198 — Modulation Effect of tACS on Chronic Low Back Pain · Phase 2 · recruiting
NCT06825390 — AuriculoTherapy NeuroImaging · NA · recruiting
NCT04824248 — Weight Reduction in CLBP · NA · recruiting
NCT07055802 — Effects Of Inversion Table Therapy Vs MT On Pain And Lumbar Flexibility In Patients With Chronic Low Back Pain · NA · active not recruiting

Other St. Ambrose University trials

Trials by the same sponsor.

NCT05715112 — Graded Motor Imagery and Fall Risk in Older Adults · completed
NCT04394494 — RCT of Motor Imagery of Extension for LBP vs. Exercise · NA · completed
NCT03760887 — A Follow-up Comparison of Sensory Discrimination in Patients With Low Back Pain · NA · completed
NCT03758807 — A Follow-up Comparison of Active Versus Passive Manual Therapy in Patients With Low Back Pain · NA · completed
NCT03170011 — Biodex Sit2Stand for Individuals With Cardiac Disease · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04023435 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Ambrose University
Last refreshed: 17 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04023435.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing